48.11MMarket Cap-1.17P/E (TTM)
1.950High1.720Low74.21KVolume1.750Open1.800Pre Close140.82KTurnover0.39%Turnover RatioLossP/E (Static)24.67MShares2.50052wk High0.65P/B36.92MFloat Cap1.29052wk Low--Dividend TTM18.93MShs Float66.440Historical High--Div YieldTTM12.78%Amplitude1.290Historical Low1.897Avg Price1Lot Size
Rafael Holdings Stock Forum
🟢 Recently Announced:
⇒ $Organon & Co (OGN.US)$ to acquire Dermavant
⇒ $Rafael Holdings (RFL.US)$ to acquire Cyclo Tx
⇒Crown Lab to acquire $Revance Therapeutics (RVNC.US)$
⇒ $Recursion Pharmaceuticals (RXRX.US)$ merger with Exscientia
🔴 Recently Closed:
⇒ $Johnson & Johnson (JNJ.US)$ acquired V-Wave
⇒ Pharmacosmos acquired $GTHX
What companies will be next? 🤔
Cyclo Therapeutics' TransportNPC(TM) Phase 3 clinical trial for Trappsol(R) Cyclo(TM) for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the 48-week interim analysis are expected in the middle of 2025
NEWARK, N.J. and GAINESVILLE, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Rafael Holdings, I...
No comment yet